Hall Laurie J Trustee Macrogenics Inc Transaction History

Hall Laurie J Trustee

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$3.01 - $5.22 $270 - $469	-90 Reduced 32.14%	190 $1,000
Q3 2021 Oct 04, 2021	SELL	$19.74 - $28.7 $3,158 - $4,592	-160 Reduced 36.36%	280 $6,000
Q1 2021 Apr 15, 2021	BUY	$18.99 - $33.2 $1,709 - $2,988	90 Added 25.71%	440 $14,000
Q4 2020 Jan 25, 2021	SELL	$19.41 - $26.0 $1,941 - $2,600	-100 Reduced 22.22%	350 $8,000
Q3 2020 Oct 09, 2020	SELL	$24.69 - $31.6 $493 - $632	-20 Reduced 4.26%	450 $11,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $12.27 $2,067 - $3,190	260 Added 123.81%	470 $5,000
Q4 2017 Jan 30, 2018	SELL	$16.19 - $20.3 $1,619 - $2,030	-100 Reduced 32.26%	210 $4,000
Q3 2017 Oct 02, 2017	BUY	$15.52 - $18.94 $1,396 - $1,704	90 Added 40.91%	310 $0
Q2 2017 Aug 22, 2017	BUY	N/A	220	220 $0

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.